<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Urology Innovations Canada</title>
	<atom:link href="https://urologyinnovationscanada.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://urologyinnovationscanada.com</link>
	<description></description>
	<lastBuildDate>Fri, 17 Jul 2026 00:22:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
	<item>
		<title>Can Prostate Cancer Be Treated Twice Without Removing the Prostate?</title>
		<link>https://urologyinnovationscanada.com/can-prostate-cancer-be-treated-twice/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Wed, 10 Jun 2026 00:51:08 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2299</guid>

					<description><![CDATA[If prostate cancer is found again after focal treatment, the next step is not automatically removal or whole-gland treatment. This article explains how UIC evaluates recurrence, new areas of cancer, repeat focal treatment options, and future treatment planning after HIFU or NanoKnife IRE.]]></description>
		
		
		
			</item>
		<item>
		<title>Follow-Up After Focal Treatment for Prostate Cancer, Including HIFU and NanoKnife (IRE)</title>
		<link>https://urologyinnovationscanada.com/prostate-cancer-focal-treatment-follow-up/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Tue, 19 May 2026 17:21:30 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2237</guid>

					<description><![CDATA[PSA monitoring is part of follow-up after any prostate cancer treatment, but focal therapy has its own rhythm. After HIFU or NanoKnife IRE, the prostate remains in place, so the key is not whether PSA disappears completely, but how it settles, changes, and guides the next step.]]></description>
		
		
		
			</item>
		<item>
		<title>How We Evaluate Men Traveling to Toronto for HIFU or NanoKnife (IRE)</title>
		<link>https://urologyinnovationscanada.com/traveling-to-toronto-for-hifu-or-nanoknife-prostate-cancer-treatment/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Wed, 06 May 2026 01:20:39 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2216</guid>

					<description><![CDATA[For men traveling from outside Toronto, UIC’s evaluation process begins before treatment is considered. MRI images, biopsy results, PSA history, prostate anatomy, and previous treatment details are reviewed to determine whether focal therapy may be appropriate. Remote review, virtual consultation, confirmatory biopsy, and treatment-day planning help create a clearer path for patients considering HIFU or NanoKnife in Toronto.]]></description>
		
		
		
			</item>
		<item>
		<title>When Active Surveillance Stops Being the Right Choice</title>
		<link>https://urologyinnovationscanada.com/when-active-surveillance-stops-being-the-right-choice/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 00:24:32 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2207</guid>

					<description><![CDATA[Active surveillance allows some men with prostate cancer to delay treatment. But it’s not always permanent. Here’s when it may be time to move from monitoring to treatment.]]></description>
		
		
		
			</item>
		<item>
		<title>Could You Still Have Prostate Cancer After a Negative Standard (TRUS) Biopsy?</title>
		<link>https://urologyinnovationscanada.com/could-you-still-have-prostate-cancer-after-a-negative-standard-trus-biopsy/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Tue, 21 Apr 2026 23:28:50 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2189</guid>

					<description><![CDATA[A negative prostate biopsy does not always rule out cancer. In some cases, the area of concern may not have been sampled. This article explains how standard TRUS biopsy works, why cancer can be missed, and how MRI-fusion biopsy can improve detection and guide next steps.]]></description>
		
		
		
			</item>
		<item>
		<title>Why Lesion Location Matters More Than Cancer Size in Focal Treatment Planning</title>
		<link>https://urologyinnovationscanada.com/why-lesion-location-matters-more-than-cancer-size-in-focal-treatment-planning/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Tue, 14 Apr 2026 16:45:10 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2177</guid>

					<description><![CDATA[In focal therapy, the size of a prostate tumor is not always the most important factor. Where the cancer is located within the prostate often determines how it can be treated and what can be preserved. This article explains why lesion location plays a critical role in treatment planning.]]></description>
		
		
		
			</item>
		<item>
		<title>Who Is Not a Good Candidate for HIFU or NanoKnife (IRE)</title>
		<link>https://urologyinnovationscanada.com/who-is-not-a-good-candidate-for-hifu-or-nanoknife-ire/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Wed, 08 Apr 2026 01:15:21 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2170</guid>

					<description><![CDATA[Not every man with prostate cancer is a candidate for focal therapy. Treatments like HIFU and NanoKnife depend on precise mapping of localized disease. When cancer is multifocal, high-volume, or difficult to define, a more comprehensive approach may be required. Understanding when focal therapy is not appropriate is key to making the right treatment decision.]]></description>
		
		
		
			</item>
		<item>
		<title>Why Some Men Need a Second Prostate Biopsy Before Choosing Focal Therapy</title>
		<link>https://urologyinnovationscanada.com/why-some-men-need-second-biopsy-before-choosing-focal-therapy/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Wed, 01 Apr 2026 00:11:47 +0000</pubDate>
				<category><![CDATA[Prostate Cancer Diagnostics]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2156</guid>

					<description><![CDATA[Some men need a second MRI-fusion biopsy before HIFU or NanoKnife to confirm the exact location, size, grade, and extent of prostate cancer. When focal treatment is designed to preserve healthy tissue, precise mapping matters. A confirmatory biopsy can reveal whether the disease is truly confined and whether focal therapy remains the right choice.]]></description>
		
		
		
			</item>
		<item>
		<title>20 Years After North America’s First HIFU</title>
		<link>https://urologyinnovationscanada.com/20-years-after-north-americas-first-hifu-prostate-cancer/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Wed, 25 Mar 2026 02:38:18 +0000</pubDate>
				<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2143</guid>

					<description><![CDATA[What two decades have taught us about focal treatment for localized prostate cancer]]></description>
		
		
		
			</item>
		<item>
		<title>Prostate Health FAQ: Your Most Common Questions, Answered</title>
		<link>https://urologyinnovationscanada.com/prostate-health-faq-your-most-common-questions-answered/</link>
		
		<dc:creator><![CDATA[Urology Innovations Canada]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 02:49:30 +0000</pubDate>
				<category><![CDATA[BPH (Benign Prostatic Hyperplasia)]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Prostate Cancer Diagnostics]]></category>
		<guid isPermaLink="false">https://urologyinnovationscanada.com/?p=2125</guid>

					<description><![CDATA[Prostate changes are common as men get older, but knowing what’s normal — and what deserves a closer look — can make the process much clearer. This FAQ covers the essentials: BPH, PSA patterns, MRI findings, and what early prostate cancer really means.]]></description>
		
		
		
			</item>
	</channel>
</rss>
